The Impact of Cannabis Use in Gastroparesis: A Propensity-Matched Analysis of 41,374 Gastroparesis Patients
Cannabis use in patients with gastroparesis seems to increase healthcare utilization. These findings underscore the need to carefully assess the risks and benefits of cannabis in gastroparesis management. Prospective studies are essential to evaluate cannabinoids' efficacy and safety in this context.
Authors
- Adam D. Farmer (ORCID: https://orcid.org/0000-0003-1902-2640)
- James K. Ruffle (ORCID: https://orcid.org/0000-0001-6248-7203)
- Mohammad Aldiabat (ORCID: https://orcid.org/0000-0002-4536-2799)
- Mohamed Mahmoud (ORCID: https://orcid.org/0000-0002-4771-4620)
- Yassine Kilani (ORCID: https://orcid.org/0000-0002-2888-160X)
- Priscila Castro Puelo
- Daniel Alejandro Gonzalez Mosquera
Institutions
- Lincoln Medical Center (US)
- Queen Mary University of London (GB)
- Washington University in St. Louis (US)
- Cornell University (US)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
- Saint Louis University (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2025-04-08
- DOI
- https://doi.org/10.14309/ajg.0000000000003479
- Citations
- 1
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.81